Assessment methods for aspirin-mediated platelet antiaggregation in type 2 diabetic patients: degree of correlation between 2 point-of-care methods

Autor: Jose Maria Cubero Gomez, Luis Pastor Torres, Pastor L. Pérez Santigosa, Francisco Javier Molano Casimiro, Maria Asunción Navarro Puerto, Juan Acosta Martínez, Francisco Sánchez Burguillos, Maria Isabel De Mier Barragan
Rok vydání: 2014
Předmět:
Zdroj: Journal of cardiovascular pharmacology. 64(1)
ISSN: 1533-4023
Popis: AIMS Impaired response to antiplatelet therapy in diabetic patients results in a higher incidence of drug-eluting stent thrombosis. This study determined the prevalence of high on-aspirin (AS) platelet reactivity in type 2 diabetic patients treated with percutaneous coronary intervention (PCI) using the VerifyNow Aspirin Assay (VN) and platelet function analyzer PFA-100 (PFA-100) and analyzed the correlation between both methods. METHODS Type 2 diabetic patients (100) with non-ST-elevation acute coronary syndrome who underwent PCI and Xience V drug-eluting stent implantation were included in this study. After PCI, platelet antiaggregation mediated by acetylsalicylic acid was assessed by VN and PFA-100. The degree of correlation and concordance was then determined. RESULTS When assayed with VN, 7% of the patients were nonresponders to aspirin (aspirin reaction units >550), and when assayed with PFA-10, 41% were nonresponders (closure time
Databáze: OpenAIRE